Kikuchi, H.
Fukuda, S.
Koike, T.
Shimodaira, Y.
Watanabe, K.
Saito, M.
Nakagawa, K.
Hatta, W.
Masamune, A.
Iijima, K.
Article History
Received: 25 April 2020
Accepted: 24 July 2020
First Online: 31 July 2020
Compliance with ethical standards
:
: The study protocol was approved by the Tohoku University Hospital Ethics Committee (2014-2-136), and all subjects provided their written informed consent prior to enrollment.
: Masamune A received lecture fees from EA Pharma Co., Ltd., Takeda Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd, and received Commercial research funding from Otsuka Pharmaceutical Co., EA Pharma Co., Ltd., Takeda Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Eisai Co., Ltd.; Iijima K received lecture fees from Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., and received Commercial research funding from Otsuka Pharmaceutical Co., Ltd., EA Pharma Co., Ltd., Takeda Pharmaceutical Co., Ltd., and Daiichi Sankyo Co., Ltd.